The pharmaceutical company AstraZeneca has defended the effectiveness of its Covid-19 vaccine after media reports said the federal government had doubts about its effectiveness in people over 65.
The Wirtschaftsblatt-Wirtschaftszeitung reported on Monday that Berlin had estimated the effectiveness of the sting for over 65-year-olds, citing sources, at only 8 percent.
Bild also said Berlin did not expect the vaccine, which was developed with Oxford University and due to receive the green light from the EU this week, would be licensed for use in the elderly, which is a significant one in many countries Poses a challenge to the introduction of plans.
“Reports that the AstraZeneca / Oxford vaccine is only 8% effective in adults over 65 years of age are completely false,” the company said in a statement late Monday.
“In November, we published data in The Lancet showing that older adults had strong immune responses to the vaccine, with 100 percent of older adults producing spike-specific antibodies after the second dose,” he added.
The European Union angrily warned AstraZeneca on Monday of the unexpected delay in delivering millions of doses of its Covid-19 vaccine to the block.
Last Friday, the pharmaceutical company said it would not meet its contractual delivery obligations to the European Union because of inexplicable “reduced earnings” in its European supply chain.
The European Union has currently approved two vaccines for wide distribution, manufactured by BioNTech / Pfizer and Moderna.
The plan was to add the AstraZeneca vaccine to this list this week, provided it would already be available and available for immediate launch.
(Except for the headline, this story was not edited by GossipMantri staff and published from a syndicated feed.)